SWCAX | VCADX | SWCAX / VCADX | |
Total Expense Ratio | 0.38 | 0.09 | 422% |
Annual Report Gross Expense Ratio | 0.41 | 0.09 | 456% |
Fund Existence | 34 years | 24 years | - |
Gain YTD | -0.296 | -0.617 | 48% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 50000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 467M | 16.5B | 3% |
Annual Yield % from dividends | 3.27 | 3.04 | 107% |
Returns for 1 year | 0.03 | -1.57 | -2% |
Returns for 3 years | 6.97 | 1.01 | 690% |
Returns for 5 years | -0.99 | -8.18 | 12% |
Returns for 10 years | 12.20 | -3.28 | -372% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CZAR | 32.21 | N/A | N/A |
Themes Natural Monopoly ETF | |||
CPSF | 24.93 | N/A | N/A |
Calamos S&P 500 Str Alt Prt ETF-Feb | |||
MLPB | 25.75 | -0.09 | -0.36% |
UBS ETRACS Alerian MLPInfrs ETN SerB | |||
BMEZ | 14.18 | -0.09 | -0.63% |
BlackRock Health Sciences Term Trust | |||
RSEE | 31.69 | -0.24 | -0.75% |
Rareview Systematic Equity ETF |